2020-13: Financial calendar 2021

26.11.2020 15:04:12 CET | Demant A/S |
Finanskalender

Selskabsmeddelelse nr. 2020-13

26. november 2020

Finanskalender for 2021
 

22. januar

Frist for indlevering af emner til dagsordenen for den ordinære generalforsamling*

19. januar til 8. februar

Stilleperiode forud for offentliggørelse af Årsrapport 2020
 

9. februar

Årsrapport 2020
 

5. marts

Ordinær generalforsamling
 

13. april til 3. maj

Stilleperiode forud for offentliggørelse af periodemeddelelse
 

4. maj

Periodemeddelelse
 

16. til 17. juni
 

Kapitalmarkedsdage

22. juli til 11. august

Stilleperiode forud for offentliggørelse af Halvårsrapport 2021
 

12. august

Halvårsrapport 2021
 

12. oktober til 1. november

Stilleperiode forud for offentliggørelse af periodemeddelelse
 

2. november

Periodemeddelelse
 

 
* Såfremt en aktionær ønsker et bestemt emne behandlet på den ordinære generalforsamling den 5. marts 2021, skal begæring herom indsendes skriftligt til bestyrelsen senest seks uger inden afholdelse af generalforsamlingen, således at begæringen er bestyrelsen i hænde senest den 22. januar 2021.

Yderligere information:
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Telefon +45 3917 7300
www.demant.com

 

 
Kontakter

Mathias Holten Møller, Director, Head of Investor Relations, +45 3913 8827, msmo@demant.com

Christian Lange, Investor Relations Officer, +45 3917 7300, chln@demant.com

Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger

Download selskabsmeddelelse.pdf

2020-13 Finanskalender 2021.pdf

26.11.2020 15:04:12 CET | Demant A/S |
Financial Calendar

Company announcement no 2020-13

26 November 2020

Financial calendar 2021
 

22 January

Deadline for submission of items for the agenda of the annual general meeting*

19 January to 8 February
 

Quiet period prior to publication of Annual Report 2020

9 February
 

Annual Report 2020

5 March
 

Annual general meeting

13 April to 3 May
 

Quiet period prior to publication of Interim Management Statement

4 May
 

Interim Management Statement

16 and 17 June

Capital Markets Days
 

22 July to 11 August
 

Quiet period prior to publication of Interim Report 2021

12 August
 

Interim Report 2021

12 October to 1 November
 

Quiet period prior to publication of Interim Management Statement

2 November
 

Interim Management Statement

 
* Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 5 March 2021, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2021.
 

Further information:
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Phone +45 3917 7300
www.demant.com

 

 
Contacts

Mathias Holten Møller, Director, Head of Investor Relations, +45 3913 8827, msmo@demant.com

Christian Lange, Investor Relations Officer, +45 3917 7300, chln@demant.com

About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments

Download announcement as PDF.pdf

2020-13 Financial calendar 2021.pdf

Leave a Reply